2026年全球外泌體診斷與治療市場報告

近年來，外泌體診斷和治療市場發展迅速。預計該市場將從2025年的6億美元成長到2026年的7.7億美元，複合年成長率（CAGR）為28.0%。這一成長被認為歸功於分子生物學研究的進步、再生醫學投資的增加、細胞外囊泡學術研究的拓展、生物技術研究基礎設施的擴充以及外泌體分析工具的日益普及。

預計未來幾年，外泌體診斷和治療市場將呈指數級成長，到2030年市場規模將達到20.7億美元，複合年成長率（CAGR）為28.0%。預測期內的成長要素包括外泌體療法臨床應用的拓展、對個人化醫療解決方案需求的不斷成長、基於人工智慧的外泌體數據分析的擴展、製藥業對生物製藥遞送系統日益成長的興趣，以及先進治療方法監管政策的逐步明朗。預測期內的主要趨勢包括外泌體在標靶藥物遞送領域的應用日益廣泛、液態生物檢體診斷技術的普及、再生醫學應用需求的成長、先進外泌體分離技術的擴展，以及對精準醫療發展的日益重視。

外泌體診斷和治療市場的預期成長主要受慢性病盛行率上升的推動。持續超過三個月且病情往往隨時間惡化的慢性病是全球重要的健康議題。外泌體可用於診斷和治療，正逐漸成為癌症領域極具潛力的生物標記物，能夠實現更靈敏的疾病監測，並促進個人化醫療的普及。根據美國國家生物技術資訊中心 (NCBI) 2023 年 1 月的預測，到 2050 年，全球慢性疾病患者人數預計將達到 1.4266 億。這項數據凸顯了慢性病盛行率上升將在推動外泌體診斷和治療市場發展方面發揮的關鍵作用。

主要企業正積極研發創新產品，例如樣品純化系統，以拓展基本客群、提升銷售額並推動營收成長。樣品純化系統是指一系列旨在去除各種樣品類型（包括DNA、RNA、蛋白質和其他生物分子）中的雜質和污染物的製程和技術。例如，2023年2月，美國領先的生物技術公司Biological Dynamics Inc.推出了ExoVerita，這是一個專為早期疾病監測和各種應用而設計的外泌體分離平台。作為該平台的一部分，ExoVita胰腺檢測已證實能夠識別特定的外泌體蛋白標記物，並利用經取得專利的ExoVerita裝置富集的血液來源外泌體樣本檢測I期和II期胰腺導管腺癌（PDAC）。該公司目前正在進行 ExoLuminate 註冊試驗 (NCT05625529)，該試驗將評估該檢驗在高風險 PDAC 患者中的臨床價值，並正在積極驗證這些發現。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球外泌體診斷和治療市場：吸引力評分和分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 人工智慧與自主智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 外泌體在標靶藥物傳遞的應用日益廣泛
  • 液態生物檢體診斷技術的日益普及
  • 對再生醫學應用的需求不斷成長
  • 擴展先進的外泌體分離技術
  • 人們越來越關注精準醫療的發展

第5章 終端用戶產業市場分析

• 學術研究機構
• 製藥公司
• 生技公司
• 醫院和診所
• CRO（受託研究機構）

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球外泌體診斷和治療市場：PESTEL 分析（政治、社會、技術、環境、法律、促進因素和限制因素）
• 全球外泌體診斷與治療市場規模、對比及成長率分析
• 全球外泌體診斷與治療市場表現：規模與成長，2020-2025年
• 全球外泌體診斷與治療市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 依產品
• 設備、軟體、試劑和試劑盒
• 透過使用
• 診斷和治療
• 最終用戶
• 學術研究機構、製藥和生物技術公司、醫院和診所以及其他最終用戶
• 按類型細分：設備
• 外泌體分離系統、表徵裝置、分析儀器
• 按類型細分：軟體
• 數據分析軟體，外泌體分析軟體
• 按類型細分：試劑和試劑盒
• 分離試劑盒、鑑定試劑、檢測試劑盒

第10章 區域與國家分析

• 全球外泌體診斷與治療市場：按地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球外泌體診斷與治療市場：依國家/地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 外泌體診斷與治療市場：競爭格局與市場佔有率，2024 年
• 外泌體診斷與治療市場：公司估值矩陣
• 外泌體診斷與治療市場：公司概況
  • Thermo Fisher Scientific Inc.
  • Miltenyi Biotec GmbH
  • Malvern Instruments Inc.
  • System Biosciences LLC
  • NanoSomix Inc.

第37章：其他領先和創新企業

• Exosome Diagnostics Inc., Evox Therapeutics Ltd., ExCoBio Inc., Codiak BioSciences Inc., Capricor Therapeutics Inc., Aethlon Medical Inc., NX Pharmagen Inc., Aegle Therapeutic Corporation, Ciloa, Sistemic Inc., Theoria Science, Mantra Bio Inc., Lonza Group AG, Bio-Techne Corp.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年外泌體診斷與治療市場：提供新機會的國家
• 2030年外泌體診斷與治療市場：提供新機會的細分領域
• 2030年外泌體診斷與治療市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Exosome diagnostics and therapeutics involve utilizing exosomes-small extracellular particles produced by cells-for both diagnostic and therapeutic purposes. Exosomes are employed in therapeutic applications as a means of delivering targeted medications, particularly within the field of regenerative medicine.

The primary products within the exosome diagnostic and therapeutic market comprise instruments, software, reagents, and kits. Instruments refer to equipment utilized for precise and accurate execution of activities or experiments. These products find diverse applications in diagnostics and therapeutics and cater to various end-users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, among others.

Tariffs are influencing the exosome diagnostic and therapeutic market by increasing costs of imported analytical instruments, isolation systems, reagents, consumables, and laboratory automation equipment. Research institutes and biotechnology companies in North America and Europe are most affected due to dependence on specialized imported tools, while Asia-Pacific faces cost pressures on manufacturing and export of research-grade systems. These tariffs are increasing research and development expenditure and slowing procurement timelines. However, they are also supporting local manufacturing of laboratory equipment, regional reagent production, and domestic innovation ecosystems for advanced biologics research.

The exosome diagnostic and therapeutic market research report is one of a series of new reports from The Business Research Company that provides exosome diagnostic and therapeutic market statistics, including exosome diagnostic and therapeutic industry global market size, regional shares, competitors with a exosome diagnostic and therapeutic market share, detailed exosome diagnostic and therapeutic market segments, market trends and opportunities, and any further data you may need to thrive in the exosome diagnostic and therapeutic industry. This exosome diagnostic and therapeutic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The exosome diagnostic and therapeutic market size has grown exponentially in recent years. It will grow from $0.6 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 28.0%. The growth in the historic period can be attributed to advancements in molecular biology research, rising investment in regenerative medicine, increasing academic research on extracellular vesicles, expansion of biotech research infrastructure, growing availability of exosome analysis tools.

The exosome diagnostic and therapeutic market size is expected to see exponential growth in the next few years. It will grow to $2.07 billion in 2030 at a compound annual growth rate (CAGR) of 28.0%. The growth in the forecast period can be attributed to increasing clinical translation of exosome therapies, rising demand for personalized medicine solutions, expansion of ai-enabled exosome data analysis, growing pharmaceutical interest in biologic delivery systems, increasing regulatory clarity for advanced therapies. Major trends in the forecast period include increasing use of exosomes for targeted drug delivery, rising adoption of liquid biopsy diagnostics, growing demand for regenerative medicine applications, expansion of advanced exosome isolation technologies, enhanced focus on precision therapeutic development.

The anticipated growth of the exosome diagnostic and therapeutic market is strongly driven by the increasing prevalence of chronic diseases. Chronic illnesses, lasting three months or more and prone to deterioration over time, are a significant health concern globally. Exosomes, utilized in both diagnostic and therapeutic capacities, emerge as promising biomarkers in cancer, enabling more sensitive disease monitoring and facilitating the accessibility of personalized medicine. In a projection from January 2023, the National Center for Biotechnology Information (NCBI) indicates a forecasted global count of 142.66 million individuals with chronic diseases by 2050. This statistic underscores the pivotal role played by the rising prevalence of chronic diseases in propelling the exosome diagnostics and therapeutics market.

Major companies are actively engaged in developing innovative products, such as sample purification systems, to expand their customer base, boost sales, and drive revenue growth. A sample purification system encompasses a suite of processes and technologies designed to eliminate impurities and contaminants from various sample types, including DNA, RNA, proteins, and other biomolecules. As an illustration, in February 2023, Biological Dynamics Inc., a prominent US-based biotechnology company, introduced ExoVerita-an exosome-isolation platform designed for early disease surveillance and diverse applications. The ExoVita Pancreas assay, part of this platform, identifies specific exosomal protein indicators and has demonstrated the ability to detect Stage 1 and Stage 2 pancreatic ductal adenocarcinoma (PDAC) using blood-based exosome samples enriched on the patented ExoVerita apparatus. The company is actively validating these findings through the ExoLuminate registry trial (NCT05625529), recruiting high-risk PDAC patients to assess the clinical value of the test.

In June 2023, Evox Therapeutics Ltd., a biotechnology company based in the UK, acquired the engEx-AAV technology platform from Codiak Biosciences for an undisclosed sum. The purpose of this acquisition is to utilize the engEx-AAV technology to improve exosome-mediated delivery systems, facilitating the advancement of innovative gene therapies and genome editors. This strategic decision aims to bolster Evox Therapeutics' capabilities in developing effective genetic medicines. Codiak Biosciences is a biopharmaceutical company located in the US that focuses on creating exosome-based therapeutics.

Major companies operating in the exosome diagnostic and therapeutic market are Thermo Fisher Scientific Inc., Miltenyi Biotec GmbH, Malvern Instruments Inc., System Biosciences LLC, NanoSomix Inc., Exosome Diagnostics Inc., Evox Therapeutics Ltd., ExCoBio Inc., Codiak BioSciences Inc., Capricor Therapeutics Inc., Aethlon Medical Inc., NX Pharmagen Inc., Aegle Therapeutic Corporation, Ciloa, Sistemic Inc., Theoria Science, Mantra Bio Inc., Lonza Group AG, Bio-Techne Corp.

North America was the largest region in the exosome diagnostic and therapeutic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the exosome diagnostic and therapeutic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The exosome diagnostic and therapeutic market consists of revenues earned by entities by providing services such as genomic sequencing, exome sequencing, resequencing, and targeted sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome diagnostic and therapeutic market also includes sales of exosome-based assays, exosome flow cytometry kits, and protein biomarker detection kits, which are used in providing exosome-based drug delivery services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exosome Diagnostic And Therapeutic Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses exosome diagnostic and therapeutic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome diagnostic and therapeutic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The exosome diagnostic and therapeutic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Instruments; Software; Reagents And Kits
• 2) By Application: Diagnostics; Therapeutic
• 3) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospitals And Clinics; Other End Users
• Subsegments:
• 1) By Instruments: Exosome Isolation Systems; Characterization Instruments; Analysis Devices
• 2) By Software: Data Analysis Software; Exosome Profiling Software
• 3) By Reagents And KITS: Isolation KITS; Characterization Reagents; Assay KITS
• Companies Mentioned: Thermo Fisher Scientific Inc.; Miltenyi Biotec GmbH; Malvern Instruments Inc.; System Biosciences LLC; NanoSomix Inc.; Exosome Diagnostics Inc.; Evox Therapeutics Ltd.; ExCoBio Inc.; Codiak BioSciences Inc.; Capricor Therapeutics Inc.; Aethlon Medical Inc.; NX Pharmagen Inc.; Aegle Therapeutic Corporation; Ciloa; Sistemic Inc.; Theoria Science; Mantra Bio Inc.; Lonza Group AG; Bio-Techne Corp.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Exosome Diagnostic And Therapeutic Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Exosome Diagnostic And Therapeutic Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Exosome Diagnostic And Therapeutic Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Exosome Diagnostic And Therapeutic Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics And Precision Medicine
  • 4.1.2 Artificial Intelligence And Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
  • 4.1.4 Industry 4.0 And Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Use Of Exosomes For Targeted Drug Delivery
  • 4.2.2 Rising Adoption Of Liquid Biopsy Diagnostics
  • 4.2.3 Growing Demand For Regenerative Medicine Applications
  • 4.2.4 Expansion Of Advanced Exosome Isolation Technologies
  • 4.2.5 Enhanced Focus On Precision Therapeutic Development

5. Exosome Diagnostic And Therapeutic Market Analysis Of End Use Industries

• 5.1 Academic And Research Institutes
• 5.2 Pharmaceutical Companies
• 5.3 Biotechnology Companies
• 5.4 Hospitals And Clinics
• 5.5 Contract Research Organizations

6. Exosome Diagnostic And Therapeutic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Exosome Diagnostic And Therapeutic Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Exosome Diagnostic And Therapeutic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Exosome Diagnostic And Therapeutic Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Exosome Diagnostic And Therapeutic Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Exosome Diagnostic And Therapeutic Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Exosome Diagnostic And Therapeutic Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Exosome Diagnostic And Therapeutic Market Segmentation

• 9.1. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Instruments, Software, Reagents And Kits
• 9.2. Global Exosome Diagnostic And Therapeutic Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostics, Therapeutic
• 9.3. Global Exosome Diagnostic And Therapeutic Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users
• 9.4. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Exosome Isolation Systems, Characterization Instruments, Analysis Devices
• 9.5. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Data Analysis Software, Exosome Profiling Software
• 9.6. Global Exosome Diagnostic And Therapeutic Market, Sub-Segmentation Of Reagents And KITS, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Isolation KITS, Characterization Reagents, Assay KITS

10. Exosome Diagnostic And Therapeutic Market Regional And Country Analysis

• 10.1. Global Exosome Diagnostic And Therapeutic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Exosome Diagnostic And Therapeutic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Exosome Diagnostic And Therapeutic Market

• 11.1. Asia-Pacific Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Exosome Diagnostic And Therapeutic Market

• 12.1. China Exosome Diagnostic And Therapeutic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Exosome Diagnostic And Therapeutic Market

• 13.1. India Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Exosome Diagnostic And Therapeutic Market

• 14.1. Japan Exosome Diagnostic And Therapeutic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Exosome Diagnostic And Therapeutic Market

• 15.1. Australia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Exosome Diagnostic And Therapeutic Market

• 16.1. Indonesia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Exosome Diagnostic And Therapeutic Market

• 17.1. South Korea Exosome Diagnostic And Therapeutic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Exosome Diagnostic And Therapeutic Market

• 18.1. Taiwan Exosome Diagnostic And Therapeutic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Exosome Diagnostic And Therapeutic Market

• 19.1. South East Asia Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Exosome Diagnostic And Therapeutic Market

• 20.1. Western Europe Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Exosome Diagnostic And Therapeutic Market

• 21.1. UK Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Exosome Diagnostic And Therapeutic Market

• 22.1. Germany Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Exosome Diagnostic And Therapeutic Market

• 23.1. France Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Exosome Diagnostic And Therapeutic Market

• 24.1. Italy Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Exosome Diagnostic And Therapeutic Market

• 25.1. Spain Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Exosome Diagnostic And Therapeutic Market

• 26.1. Eastern Europe Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Exosome Diagnostic And Therapeutic Market

• 27.1. Russia Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Exosome Diagnostic And Therapeutic Market

• 28.1. North America Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Exosome Diagnostic And Therapeutic Market

• 29.1. USA Exosome Diagnostic And Therapeutic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Exosome Diagnostic And Therapeutic Market

• 30.1. Canada Exosome Diagnostic And Therapeutic Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Exosome Diagnostic And Therapeutic Market

• 31.1. South America Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Exosome Diagnostic And Therapeutic Market

• 32.1. Brazil Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Exosome Diagnostic And Therapeutic Market

• 33.1. Middle East Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Exosome Diagnostic And Therapeutic Market

• 34.1. Africa Exosome Diagnostic And Therapeutic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Exosome Diagnostic And Therapeutic Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Exosome Diagnostic And Therapeutic Market Regulatory and Investment Landscape

36. Exosome Diagnostic And Therapeutic Market Competitive Landscape And Company Profiles

• 36.1. Exosome Diagnostic And Therapeutic Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Exosome Diagnostic And Therapeutic Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Exosome Diagnostic And Therapeutic Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Miltenyi Biotec GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Malvern Instruments Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. System Biosciences LLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. NanoSomix Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Exosome Diagnostic And Therapeutic Market Other Major And Innovative Companies

• Exosome Diagnostics Inc., Evox Therapeutics Ltd., ExCoBio Inc., Codiak BioSciences Inc., Capricor Therapeutics Inc., Aethlon Medical Inc., NX Pharmagen Inc., Aegle Therapeutic Corporation, Ciloa, Sistemic Inc., Theoria Science, Mantra Bio Inc., Lonza Group AG, Bio-Techne Corp.

38. Global Exosome Diagnostic And Therapeutic Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Exosome Diagnostic And Therapeutic Market

40. Exosome Diagnostic And Therapeutic Market High Potential Countries, Segments and Strategies

• 40.1 Exosome Diagnostic And Therapeutic Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Exosome Diagnostic And Therapeutic Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Exosome Diagnostic And Therapeutic Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer